fluocinolone acetonide has been researched along with Chloasma in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.13) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (37.50) | 29.6817 |
| 2010's | 12 (37.50) | 24.3611 |
| 2020's | 7 (21.88) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, L; Perveen, S; Rao, B; Rubin, A; Sharif, S; Waqas, N; Xiong, W | 1 |
| Blicharz, L; Galadari, H; Gold, MH; Goldman, MP; Goldust, M; Kassir, M; Konnikov, N; Mahajan, VK; Patil, A | 1 |
| Bagatin, E; de Freitas, ACP; Leonardi, GR; Rigon, RB | 1 |
| Chang, CC; Chang, TM; Chen, YT; Chiang, HM; Chiu, PC; Huang, YH; Lin, BS; Lin, ET; Lin, HY; Wang, KY; Wang, YJ | 1 |
| Andanooru Chandrappa, NK; Banavase Channakeshavaiah, R | 1 |
| de Abreu, L; de Barros, MH; Ramírez-Oliveros, JF; Tamler, C; Vilhena, P | 1 |
| Jawade, S; Kulkarni, S; Madke, B; Sahu, PJ; Saoji, V; Singh, AL | 1 |
| Cabrera-Alonso, R; González, FJ; Guevara, E; Moncada, B; Ramírez-Elías, MG | 1 |
| Dreher, F; Monheit, GD | 1 |
| Fernandes, JD; Hexsel, D; Siega, C; Soirefmann, M | 1 |
| Dang, Y; Gong, Z; Lai, W; Li, L; Liu, L; Wang, X; Yang, Q; Zhao, G; Zheng, M; Zou, Y | 1 |
| Chan, R; Chang, SE; Kerrouche, N; Lee, ES; Lee, MH; Legarda-Montinola, F; Leow, YH; Park, KC; Shek, S; Tay, YK; Thomas, G; Tsai, RY; Tsai, TH; Verallo-Rowell, V | 1 |
| Benitez, AL; Bussear, EW; Cardona, LM; Colón, LE; Johnson, LA; Rendon, M | 1 |
| Arellano, I; Cestari, T; Hexsel, D; Ortonne, JP | 1 |
| Bhawan, J; Byers, HR; Colón, LE; Gottschalk, R; Grimes, P; Guevara, IL; Johnson, LA; Keady, M; Pandya, AG | 1 |
| Alikhan, A; Balkrishnan, R; Daly, M; Feldman, SR; Wu, J | 1 |
| Jeong, SY; Kim, IH; Kim, WS; Shin, JB; Yeo, UC | 1 |
| Bhawan, J; Colón, LE; Gottschalk, RW; Grimes, PE; Guevara, IL; Johnson, LA; Pandya, AG | 1 |
| Draelos, Z | 1 |
| Colón, LE; Gold, MH; Goldman, MP; Gottschalk, RW; Johnson, LA; Palm, MD; Preston, N | 1 |
| Godse, KV; Sakhia, J | 1 |
| Arellano, I; Azulay-Abulafia, L; Bezerra Trindade Neto, P; Cestari, T; Hexsel, D; Machado-Pinto, J; Marques-Hassun, K; Muñoz, H; Ocampo-Candiani, J; Paliargues, F; Rego, V; Rivitti-Machado, MC; Sittart, JA; Trindade de Almeida, AR | 1 |
| Bahadoran, P; Fontas, E; Kang, HY; Lacour, JP; Ortonne, JP; Passeron, T | 1 |
| Baumann, L; Jarratt, MM; Jones, T; Lowe, N; Martin, D; Menter, A; Pariser, D; Ramirez, N; Rich, P; Shavin, J; Taylor, SC; Torok, H; Tschen, E; Weiss, J; Wieder, JJ | 1 |
| Jones, T; Rich, P; Smith, S; Torok, HM; Tschen, E | 1 |
| Grimes, P; Kelly, AP; Torok, H; Willis, I | 1 |
| Torok, HM | 1 |
| Almeida, AR; Azulay, L; Cestari, TF; Filho, JW; Hassun, K; Hexsel, D; Junqueira, H; Mendes, AM; Rêgo, VR; Viegas, ML | 1 |
| de Lourdes Viegas, M; Ferreira Cestari, T; Hassun, K; Sittart, A | 1 |
| Adjadj, L; Cestari, T; Hux, M; Rives, VP; Shimizu, MR | 1 |
| Grimes, PE | 1 |
| Jarratt, M; Ramsdell, W | 1 |
3 review(s) available for fluocinolone acetonide and Chloasma
| Article | Year |
|---|---|
Medical therapies for melasma.
Topics: Adrenal Cortex Hormones; Cosmeceuticals; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Quality of Life; Silicones; Sunscreening Agents; Tranexamic Acid; Treatment Outcome; Tretinoin; Zinc Oxide | 2022 |
Melasma in Latin America: options for therapy and treatment algorithm.
Topics: Algorithms; Drug Therapy, Combination; Evidence-Based Medicine; Fluocinolone Acetonide; Humans; Hydroquinones; Latin America; Melanosis; Quality of Life; Tretinoin | 2009 |
A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream.
Topics: Administration, Cutaneous; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Melanosis; Time Factors; Tretinoin | 2006 |
19 trial(s) available for fluocinolone acetonide and Chloasma
| Article | Year |
|---|---|
A Randomized Trial of Oral Tranexamic Acid With Fluocinolone-Based Triple Cream Versus Fluocinolone Based Triple Cream Alone for the Treatment of Melasma.
Topics: Fluocinolone Acetonide; Humans; Hyperpigmentation; Melanosis; Tranexamic Acid; Treatment Outcome | 2022 |
Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma.
Topics: Adult; Asian People; Combined Modality Therapy; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Lasers, Solid-State; Melanosis; Middle Aged; Ointments; Prospective Studies; Single-Blind Method; Treatment Outcome; Tretinoin | 2020 |
Topical metformin in the treatment of melasma: A preliminary clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Metformin; Middle Aged; Ointments; Patient Satisfaction; Prospective Studies; Severity of Illness Index; Skin Lightening Preparations; Skin Pigmentation; Treatment Outcome; Tretinoin; Young Adult | 2020 |
Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Drug Combinations; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Prospective Studies; Severity of Illness Index; Sunscreening Agents; Tranexamic Acid; Treatment Outcome; Tretinoin; Young Adult | 2020 |
Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Dermatologic Agents; Drug Combinations; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Melanosis; Middle Aged; Severity of Illness Index; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome; Tretinoin; Young Adult | 2013 |
Objective assessment of erythema and pigmentation of melasma lesions and surrounding areas in long-term management regimens with triple combination.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antioxidants; Drug Therapy, Combination; Erythema; Fluocinolone Acetonide; Humans; Hydroquinones; Keratolytic Agents; Long-Term Care; Maintenance Chemotherapy; Melanins; Melanosis; Prospective Studies; Single-Blind Method; Skin; Skin Pigmentation; Tretinoin; Young Adult | 2014 |
Efficacy and safety of fluocinolone acetonide, hydroquinone, and tretinoin cream in chinese patients with melasma: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study.
Topics: Adolescent; Adult; Asian People; Double-Blind Method; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Tretinoin; Young Adult | 2015 |
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Asian People; Double-Blind Method; Drug Combinations; Facial Dermatoses; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Ointments; Patient Satisfaction; Treatment Outcome; Tretinoin | 2008 |
Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
Topics: Administration, Cutaneous; Adult; Chemexfoliation; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Follow-Up Studies; Glycolates; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Ointments; Pilot Projects; Severity of Illness Index; Treatment Outcome; Tretinoin | 2008 |
A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream.
Topics: Administration, Cutaneous; Adult; Atrophy; Dermatologic Agents; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Skin; Tretinoin | 2009 |
Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
Topics: Administration, Topical; Adult; Antioxidants; Combined Modality Therapy; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Lasers, Solid-State; Male; Melanosis; Middle Aged; Treatment Outcome; Tretinoin | 2010 |
Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma.
Topics: Adult; Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Keratolytic Agents; Low-Level Light Therapy; Male; Melanosis; Middle Aged; Radiation-Protective Agents; Tretinoin | 2011 |
Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity.
Topics: Dermatologic Agents; Drug Therapy, Combination; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Quality of Life; Recurrence; Severity of Illness Index; Surveys and Questionnaires; Tretinoin | 2012 |
Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study.
Topics: Adult; Bleaching Agents; Dermatologic Agents; Drug Combinations; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Lasers, Dye; Melanosis; Middle Aged; Patient Satisfaction; Single-Blind Method; Tretinoin | 2011 |
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
Topics: Administration, Topical; Adult; Aged; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Facial Dermatoses; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Melanosis; Middle Aged; Ointments; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Tretinoin | 2003 |
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.
Topics: Antioxidants; Drug Combinations; Facial Dermatoses; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Male; Melanosis; Middle Aged; Ointments; Treatment Outcome; Tretinoin | 2005 |
Community-based trial of a triple-combination agent for the treatment of facial melasma.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Dermatologic Agents; Drug Combinations; Facial Dermatoses; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Ointments; Prospective Studies; Treatment Outcome; Tretinoin; United States | 2006 |
A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma.
Topics: Administration, Topical; Adult; Drug Combinations; Emollients; Facial Dermatoses; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Tretinoin | 2007 |
Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma.
Topics: Administration, Topical; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Treatment Outcome; Tretinoin | 2007 |
10 other study(ies) available for fluocinolone acetonide and Chloasma
| Article | Year |
|---|---|
Perspectives of topical formulations for melasma.
Topics: Female; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Retinoids; Sunscreening Agents; Treatment Outcome; Tretinoin | 2023 |
Microneedling with Drug Delivery (Hydroquinone 4% Serum) as an Adjuvant Therapy for Recalcitrant Melasma.
Topics: Adult; Combined Modality Therapy; Cosmetic Techniques; Dermatologic Agents; Drug Delivery Systems; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Hydroquinones; Melanosis; Needles; Quality of Life; Sunscreening Agents; Treatment Outcome; Tretinoin | 2020 |
Detection of hydroquinone by Raman spectroscopy in patients with melasma before and after treatment.
Topics: Adult; Drug Monitoring; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Precision Medicine; Skin; Skin Lightening Preparations; Spectrum Analysis, Raman; Treatment Outcome; Tretinoin; Young Adult | 2019 |
Cost-effectiveness of a hydroquinone/tretinoin/fluocinolone acetonide cream combination in treating melasma in the United States.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Drug Costs; Drug Therapy, Combination; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Ointments; Treatment Outcome; Tretinoin; United States | 2010 |
Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.
Topics: Administration, Topical; Adolescent; Adult; Aged; Drug Administration Schedule; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Male; Melanosis; Middle Aged; Ointments; Skin Pigmentation; Tretinoin; Young Adult | 2010 |
Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
Topics: Administration, Topical; Antioxidants; Combined Modality Therapy; Drug Combinations; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Lasers, Solid-State; Melanosis; Tretinoin | 2011 |
Triple combination and glycolic acid peels in melasma in Indian patients.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Antioxidants; Chemexfoliation; Drug Combinations; Face; Female; Fluocinolone Acetonide; Glycolates; Humans; Hydroquinones; India; Keratolytic Agents; Male; Melanosis; Middle Aged; Treatment Outcome; Tretinoin; Young Adult | 2011 |
Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
Topics: Adult; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Hydroquinones; Keratolytic Agents; Language; Male; Melanosis; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Tretinoin | 2006 |
An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
Topics: Administration, Topical; Adult; Antioxidants; Female; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Middle Aged; Treatment Outcome; Tretinoin; Vitamin A | 2007 |
Infantile acropustulosis.
Topics: Child, Preschool; Diagnosis, Differential; Eczema; Erythema; Female; Fluocinolone Acetonide; Fluocinonide; Histamine Antagonists; Humans; Infant; Infant, Newborn; Male; Melanosis; Pruritus; Psoriasis; Skin Diseases, Infectious; Triamcinolone Acetonide | 1979 |